Molecular heterogeneity in metastatic breast cancer presents multiple clinical challenges in
accurately characterizing and treating the disease. Current diagnostic approaches offer …

Mechanisms of therapeutic resistance and vulnerability evolve in metastatic cancers as tumor
cells and extrinsic microenvironmental influences change during treatment. To support the …

Background In order to establish the workflows required to implement a real-time process
involving multi-omic analysis of patient samples to support precision-guided therapeutic …

In a pilot study, we evaluated the feasibility of real-time deep analysis of serial tumor
samples from triple negative breast cancer patients to identify mechanisms of resistance and …

TPS8604 Background: Neoadjuvant platinum-based CT plus IO prolongs event-free survival
(EFS) and increases pathological complete response (pCR) rate in patients with resectable …

Purpose: COVID-19 had a significant impact on undergraduate medical education. There
has been extensive analysis on the generic impact on medical education, but the individual …

TPS1111 Background: There is an urgent need to develop novel non chemotherapy treatments
for metastatic triple negative breast cancer (mTNBC) patients who otherwise have a poor …

SMMART is a precision medicine research program focused on understanding the evolution
of actionable biology and mechanisms of resistance in human tumors during therapy. This …

Leaching of ions from geological samples was carried out by various economically viable
methods. Results were compared to evaluate each method in aspects of creating state of art …

The human epidermal growth factor receptor 3 (ERBB3/HER3) is a transmembrane receptor
tyrosine kinase belonging to the ERBB/HER family of receptor tyrosine kinases. 1, 2 ERBB3 …